JOINN Biologics US sells a deceptively practical service: finding out early whether a brilliant biologic can be made, measured and supplied. Its Richmond team now applies that logic from antibody screening to a 2026 biosimilar partnership.
A biologic medicine begins with cells and the liquid that keeps them alive. OPM built a business around that liquid, then followed its customers all the way to the factory floor.